Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain

Radiology

Volumn 281, Issue 2, 2016, Pages 516-526

  Rodriguez, Pavel ^a   Zhou, Wei ^a   Barrett, Douglas W ^b   Altmeyer, Wilson ^a   Gutierrez, Juan E ^a   Li, Jinqi ^a   Lancaster, Jack L ^a   Gonzalez Lima, Francisco ^b   Duong, Timothy Q ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; METHYLENE BLUE; PLACEBO; ENZYME INHIBITOR;

ADULT; ALERTNESS; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HUMAN EXPERIMENT; INSULA; LOW DRUG DOSE; MALE; NORMAL HUMAN; OCCIPITAL CORTEX; PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SHORT TERM MEMORY; TIME; ATTENTION; DRUG EFFECTS; IMAGE PROCESSING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PROCEDURES; PSYCHOMOTOR PERFORMANCE; TASK PERFORMANCE;

ADMINISTRATION, ORAL; ADULT; ATTENTION; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; METHYLENE BLUE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; TASK PERFORMANCE AND ANALYSIS;

EID: 84992092232     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2016152893     Document Type: Review

References (38)

1. Clifton J 2nd, Leikin JB. Methylene blue. Am J Ther 2003;10(4):289-291.
2. Scheindlin S. Something old. something blue. Mol Interv 2008;8(6):268-273.
3. Peter C, Hongwan D, Küpfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol 2000;56(3): 247-250.
4. Walter-Sack I, Rengelshausen J, Oberwittler H, et al. High absolute bioavailability of methylene blue given as an aqueous oral formulation. Eur J Clin Pharmacol 2009;65 (2):179-189.
5. Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol 2012;96(1): 32-45.
6. Callaway NL, Riha PD, Bruchey AK, Munshi Z, Gonzalez-Lima F. Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol Biochem Behav 2004;77(1):175-181.
7. Riha PD, Bruchey AK, Echevarria DJ, Gonzalez-Lima F. Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur J Pharmacol 2005;511(2-3):151-158.
8. Huang S, Du F, Shih YY, Shen Q, Gonzalez-Lima F, Duong TQ. Methylene blue potentiates stimulus-evoked fMRI responses and cerebral oxygen consumption during normoxia and hypoxia. Neuroimage 2013;72:237-242.
9. Gonzalez-Lima F, Bruchey AK. Extinction memory improvement by the metabolic enhancer methylene blue. Learn Mem 2004; 11(5):633-640.
10. Martinez JL, Jensen RA, Vasquez BJ, Mc-Guinness T, McGaugh JL. Methylene-blue alters retention of inhibitory avoidance responses. Physiol Psychol 1978;6(3):387-390.
11. Wrubel KM, Riha PD, Maldonado MA, Mc-Collum D, Gonzalez-Lima F. The brain metabolic enhancer methylene blue improves discrimination learning in rats. Pharmacol Biochem Behav 2007;86(4):712-717.
12. Callaway NL, Riha PD, Wrubel KM, McCollum D, Gonzalez-Lima F. Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci Lett 2002;332(2):83-86.
13. Riha PD, Rojas JC, Gonzalez-Lima F. Beneficial network effects of methylene blue in an amnestic model. Neuroimage 2011;54(4): 2623-2634.
14. Gonzalez-Lima F, Barksdale BR, Rojas JC. Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem Pharmacol 2014;88(4):584-593.
15. Bruchey AK, Gonzalez-Lima F. Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue. Am J Pharmacol Toxicol 2008;3(1):72-29
16. Hochgräfe K, Sydow A, Matenia D, et al. Preventive methylene blue treatment preserves cognition in mice expressing fulllength pro-aggregant human Tau. Acta Neuropathol Commun 2015;3:25.
17. Wischik CM, Staff RT, Wischik DJ, et al. Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease. J Alzheimers Dis 2015;44(2):705-720.
18. Telch MJ, Bruchey AK, Rosenfield D, et al. Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. Am J Psychiatry 2014;171(10):1091-1098.
19. Mueller ST, Piper BJ. The psychology experiment building language (PEBL) and PEBL test battery. J Neurosci Methods 2014;222: 250-259.
20. Gläscher J, Gitelman D. Contrast weights in flexible factorial design with multiple groups of subjects. http://www.sbirc.ed.ac.uk/cyril/download/Contrast-Weighting-Glascher-Gitelman-2008.pdf. Published March 18, 2008. Accessed December ##, 2015.
21. David SP, Sweet LH, Cohen RA, MacKillop J, Mulligan RC, Niaura R. Application of functional neuroimaging to examination of nicotine dependence. In: Cohen RA, Sweet LH, eds. Brain imaging in behavioral medicine and clinical neuroscience. New York, NY: Springer, 2011; 117-145.
22. Kurth F, Zilles K, Fox PT, Laird AR, Eickhoff SB. A link between the systems: functional differentiation and integration within the human insula revealed by metaanalysis. Brain Struct Funct 2010;214(5-6): 519-534.
23. Picchioni M, Matthiasson P, Broome M, et al. Medial temporal lobe activity at recognition increases with the duration of mnemonic delay during an object working memory task. Hum Brain Mapp 2007;28(11):1235-1250.
24. Hedden T, Gabrieli JD. The ebb and flow of attention in the human brain. Nat Neurosci 2006;9(7):863-865.
25. Mutschler I, Wieckhorst B, Kowalevski S, et al. Functional organization of the human anterior insular cortex. Neurosci Lett 2009;457(2):66-70.
26. Habeck C, Rakitin BC, Moeller J, et al. An event-related fMRI study of the neural networks underlying the encoding, maintenance, and retrieval phase in a delayedmatch-to-sample task. Brain Res Cogn Brain Res 2005;23(2-3):207-220.
27. Lim J, Wu WC, Wang J, Detre JA, Dinges DF, Rao H. Imaging brain fatigue from sustained mental workload: an ASL perfusion study of the time-on-task effect. Neuroimage 2010;49(4):3426-3435.
28. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996;4(1):58-73.
29. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 2005;102(27):9673-9678.
30. Fox KC, Spreng RN, Ellamil M, Andrews-Hanna JR, Christoff K. The wandering brain: meta-analysis of functional neuroimaging studies of mind-wandering and related spontaneous thought processes. Neuroimage 2015;111:611-621.
31. Sepede G, Spano MC, Lorusso M, et al. Sustained attention in psychosis: Neuroimaging findings. World J Radiol 2014;6(6):261-273.
32. Kuhl BA, Bainbridge WA, Chun MM. Neural reactivation reveals mechanisms for updating memory. J Neurosci 2012;32(10):3453-3461.
33. Feurra M, Fuggetta G, Rossi S, Walsh V. The role of the left inferior frontal gyrus in episodic encoding of faces: An interference study by repetitive transcranial magnetic stimulation. Cogn Neurosci 2010;1(2):118-125.
34. Grady CL, Protzner AB, Kovacevic N, et al. A multivariate analysis of age-related differences in default mode and task-positive networks across multiple cognitive domains. Cereb Cortex 2010;20(6):1432-1447.
35. Ma WJ, Husain M, Bays PM. Changing concepts of working memory. Nat Neurosci 2014;17(3):347-356.
36. Mars RB, Grol MJ. Dorsolateral prefrontal cortex, working memory, and prospective coding for action. J Neurosci 2007; 27(8):1801-1802.
37. Balconi M. Dorsolateral prefrontal cortex, working memory and episodic memory processes: insight through transcranial magnetic stimulation techniques. Neurosci Bull 2013;29(3):381-389.
38. Lin AL, Poteet E, Du F, et al. Methylene blue as a cerebral metabolic and hemodynamic enhancer. PLoS One 2012;7(10):e46585.